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Summary
BACKGROUND: The writing of prescriptions is an im-
portant aspect of medical practice. This activity presents
some specific problems given a danger of misinterpretation
and dispensing errors in community pharmacies. The ob-
jective of this study was to determine the evolution of the
prescription practice and writing quality in the outpatient
clinics of our paediatric university hospital.
METHODS: Copies of prescriptions written by physicians
were collected from community pharmacies in the region
of our hospital for a two-month period in 2005 and 2010.
They were analysed according to standard criteria, includ-
ing both formal and pharmaceutical aspects.
RESULTS: A total of 597 handwritten prescriptions were
reviewed in 2005 and 633 in 2010. They contained 1,456
drug prescriptions in 2005 and 1,348 in 2010. Fifteen drugs
accounted for 80% of all prescriptions and the most com-
mon drugs were paracetamol and ibuprofen. A higher pro-
portion of drugs were prescribed as International Nonpro-
prietary Names (INN) or generics in 2010 (24.7%) com-
pared with 2005 (20.9%). Of the drug prescriptions ex-
amined, 55.5% were incomplete in 2005 and 69.2% in
2010. Moreover in 2005, 3.2% were legible only with diffi-
culty, 22.9% were ambiguous, and 3.0% contained an error.
These proportions rose respectively to 5.2%, 27.8%, and
6.8% in 2010.
CONCLUSION: This study showed that fifteen different
drugs represented the majority of prescriptions, and a
quarter of them were prescribed as INN or generics in
2010; and that handwritten prescriptions contained numer-
ous omissions and preventable errors. In our hospital com-
puterised prescribing coupled with advanced decision sup-
port is eagerly awaited.
Key words: drug; prescribing; quality; paediatrics;
outpatients
Introduction
Patient safety is a priority in healthcare systems across
the world [1, 2]. Evidence suggests that medication errors
could have a higher incidence in infants and children than
in adults [3, 4]. Most drug doses are calculated according
to the patient’s age, weight (or body surface), and clinical
conditions. Another potential for errors is the variety of
pharmaceutical forms and dosages available for paediatric
patients (suspensions, syrups, tablets, capsules, supposit-
ories, etc.) or sometimes the lack of an appropriate for-
mulation necessitating extemporaneous compounding. Fin-
ally, young children cannot reliably self-administer, monit-
or drug use, and communicate about adverse events.
The paper prescription form is still the main mean of com-
munication between the physician, the patient, and the
community pharmacy in most countries. Ideally, a prescrip-
tion should be legible, precise, complete, and unambiguous
in its interpretation. Drug prescribing errors occur at rates
as high as 4.2% in paediatric inpatients [5]. Limited work
has been carried out to investigate medication errors in pae-
diatric outpatients [6–10].
Since 2001, community pharmacists in Switzerland have
the ability to replace original drugs by generic ones for
economical reasons. In 2006, the Swiss authorities decided
to impose definite incentives to physicians to improve the
proportion of generic substitutions [11]. To our knowledge,
the influence of these incentives has not been assessed in
paediatric outpatients.
This study had two objectives: (1) to determine the evolu-
tion of the outpatient prescription practice in our paediatric
university hospital during two periods (2005 and 2010), es-
pecially regarding generic drugs; (2) to assess the writing
quality of the outpatient prescriptions during the same peri-
ods.
Patients and methods
This study was prospectively conducted over a two-month
period (from January to March 2005 and from January
to March 2010) at the Children’s Hospital of Lausanne
(HEL, French abbreviations). The protocol was accepted
by the local Ethics Committee of the Faculty of Biology
and Medicine of the University of Lausanne.
The HEL is a general paediatric teaching hospital attached
to the university hospital of Lausanne. Every year, more
than 50,000 patients come to the outpatient clinics of the
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HEL. Among them, more than 29,000 consult the Emer-
gency Department. The paper prescription form contains
only the pre-printed hospital address and phone number
and thirty different medical or surgical physicians hand-
write the drugs onto prescriptions for the patient's commu-
nity pharmacy. Every six months since 2004, instruction
by a senior pharmacist on good prescribing practice is in-
cluded in the training programme for junior physicians.
A letter was sent to community pharmacists of the region
of our hospital, explaining the aim of the study and asking
them to photocopy handwritten prescriptions from the
HEL. In order not to introduce bias, the prescribers were
informed about the study only once prescriptions had been
collected. Copies of the prescriptions were sent to the ju-
nior investigators (LOR and GS) and senior pharmacist
(EDP) and screened separately by them. Only prescriptions
of the outpatient clinics of the HEL were analysed.
The criteria set to evaluate the quality of prescriptions were
chosen in accordance with the rules of our institution and
to the taxonomy of NCC MERP [2]. The formal criteria re-
garding the prescribers were as follows: date, physician’s
name, stamp, and signature. The formal criteria regarding
the patients were as follows: surname, first name, date of
birth or age, gender, weight, and patient’s label. The last
three criteria were optional. The formal criteria regarding
the drug prescriptions were as follows: drug name, pharma-
ceutical form, strength or concentration, dose, frequency of
administration, quantity or number of packages, treatment
duration, route of administration, and instructions to pa-
tients. The last three criteria were optional, except for anti-
biotic treatments where duration was mandatory.
Patient’s names and drug prescriptions were classified as
“legible”, “legible with difficulty”, or “illegible”. If the in-
vestigators could not read the prescription (or a part of it),
it was considered “legible with difficulty” or “illegible”,
and the opinion of other colleagues in the pharmacy de-
partment was sought. Drug prescriptions were classified as
“complete” or “incomplete.” In “complete” prescriptions,
the following criteria were fulfilled: drug name, pharma-
ceutical form, strength or concentration, dose, frequency
of administration, and quantity or number of packages. In
the “incomplete” prescriptions, one (or more) criterion was
missing. According to a previous study in our hospital [12],
incomplete prescriptions were further classified as “unam-
biguous” or “ambiguous.” Prescriptions were unambigu-
ous when all criteria were present or when one (or more)
safety criterion was missing but no misinterpretation was
possible. Prescriptions were considered ambiguous when
one (or more) safety criterion was missing, and at least
one alternative solution existed for correct understanding
and execution. Finally, a “prescribing error” was defined
as follows: illegible drug, drug out of the market, wrong
drug name, wrong pharmaceutical form, wrong strength or
concentration, wrong dose or frequency of administration,
wrong quantity or number of packages, wrong duration for
the treatment, or wrong route of administration. The eval-
uation of the interventions by community pharmacists was
beyond the scope of the study.
The reference information database was the Swiss Drug
Compendium [13] and Pharmavista database [14]. The of-
ficial list of Swiss pharmaceutical specialities was used to
identify drugs reimbursed by insurance and generic drugs
[15]. If not available in these databases, drug doses were
checked in specific paediatric databases [16, 17]. If the pa-
tient’s weight was omitted, their age may permit estimated
drug doses. Data were collected in a database and sum-
marised using standard descriptive methods. The t-test was
used to compare mean numbers of drugs, and the Fisher’s
exact test was used to compare frequencies [18].
Results
Of the 127 and 99 community pharmacies contacted, 39
(31%) and 40 (40%), respectively, sent back prescriptions
originating with the HEL during the two periods under
study. The total of prescriptions analysed was 597 for 2005
and 633 for 2010. They contained 1,456 and 1,348 drug
prescriptions, respectively, that is, a mean number of 2.4 ±
1.3 drugs (range: 1–9) in 2005 and 2.1 ± 1.1 drugs (range:
1–7) in 2010 (p <0.0001).
The mean age of the patients was 5.4 ± 4.4 years in 2005
and 6.2 ± 4.8 years in 2010. The majority of patients ranged
from 1 to 23 months (27.1% in 2005 and 26.2% in 2010, p
= 0.75) and from 2 to 11 years (59.5% in 2005 and 56.1%
in 2010, p = 0.25). The other patients were neonates (0.3%
in 2005 and 0.5% in 2010, p = 1.0) and adolescents (13.1%
in 2005 and 17.2% in 2010, p = 0.05).
The 15 most frequently prescribed drugs in 2005 and 2010
are listed in table 1. They represented about 80% of all
drugs. Paracetamol, ibuprofen, and normal saline nose
drops were the most used drugs during the two study peri-
ods. The most common routes of administration were as
follows: oral (47.5% of the total of drugs in 2005, 59.3%
in 2010), nasal (18.7% in 2005, 14.8% in 2010), and rectal
(15.5% in 2005, 7.2% in 2010).
Of the 1,456 drug prescriptions, 1,110 were reimbursed by
the patient’s health insurance (76.2%) in 2005, and of the
1,348 drug prescriptions, 1,127 were reimbursed in 2010
(83.6%, p <0.0001). A higher proportion of drugs were
prescribed as INN or generics in 2010 (24.7%) compared
with those prescribed in 2005 (20.9%, p = 0.0168). Twenty
drugs were extemporaneous preparations in 2005 and 17,
in 2010.
The formal criteria regarding prescribers and patients are
presented in table 2. The date of prescriptions and the pa-
tient’s weight were entered more frequently in 2010. In
contrast, the patient’s date of birth was missing more often
in 2010, and the patient's labels were less used in 2010.
Formal criteria regarding the drug prescriptions are presen-
ted in table 3. Amongst them, 185 medicines were pre-
scribed by just giving the name(s) of the drug in 2005. In
2010 this number was 197.
Prescription problems and errors are detailed in table 4.
The number of poorly legible, incomplete or ambiguous
drug prescriptions and errors significantly increased from
2005 to 2010. The total number of errors rose from 43 in
2005 to 92 in 2010. Amongst those errors, 7 were wrong
doses in 2005, and 12 in 2010. Examples of overdosing er-
rors included paracetamol (>100 mg/kg/day for children)
and examples of under dosing errors included ibuprofen
(<5 mg/kg/dose for children).
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Discussion
In this study carried out in the paediatric outpatient clinics
of our hospital during two periods, we showed that (1) fif-
teen different drugs accounted for 80% of all prescriptions,
and a quarter of them were prescribed as INN or generics in
2010; and (2) handwritten prescriptions contained numer-
ous omissions and preventable errors.
One third of community pharmacies responded to our
study. We can estimate that the number of analysed pre-
scriptions was representative of the outpatient practice of
the HEL during the two periods. The average age of pa-
tients was slightly higher in 2010 compared with those in
2005. This difference was mainly due to a higher propor-
tion of teenagers in 2005. The average number of drugs per
patient was relatively modest and even decreased in 2010.
Table 1: The 15 drugs most frequently prescribed in 2005 and 2010.
2005 2010
Rank Drugs n (%) Rank Drugs n (%)
1 Paracetamol (acetaminophen) 334 (22.9) 1 Ibuprofen 303 (22.5)
2 Ibuprofen 230 (15.8) 2 Paracetamol (acetaminophen) 301 (22.3)
3 Normal saline (nose drops) 159 (10.9) 3 Normal saline (nose drops) 120 (8.9)
4 Chlorhexidine – oxybuprocaine 70 (4.8) 4 Amoxicillin 89 (6.6)
5 Amoxicillin 60 (4.1) 5 Oxymetazoline (nasal) 48 (3.6)
6 Oxomemazine – guaifenesin – sodium benzoate* 46 (3.2) 6 Oral rehydration solution 46 (3.4)
7 Xylometazoline (nasal) 33 (2.3) 7 Salbutamol (albuterol) 34 (2.5)
8 Codeine – phenyltoloxamine* 33 (2.3) 8 Amoxicillin – clavulanic acid 24 (1.8)
9 Mefenamic acid 30 (2.1) 9 Phenoxymethylpenicillin 23 (1.7)
10 Phenylephrine (nasal)* 29 (2.0) 10 Dimethindene 22 (1.6)
11 Amoxicillin – clavulanic acid 29 (2.0) 11 Polymyxin B – neomycin (ocular) 17 (1.3)
12 Salbutamol (albuterol) 28 (1.9) 12 Mefenamic acid 14 (1.0)
13 Oxymetazoline (nasal) 26 (1.8) 13 Xylometazoline (nasal) 14 (1.0)
14 Xylometazoline-carbocysteine (nasal) 24 (1.6) 14 Chamomile extract 13 (1.0)
15 Phenoxymethylpenicillin 23 (1.6) 15 Chlorhexidine – oxybuprocaine 13 (1.0)
Total (15 drugs) 1,154 (79.3) Total (15 drugs) 1,081 (80.2)
Total (all drugs) 1,456 (100.0) Total (all drugs) 1,348 (100.0)
* Out of the market in 2010.
Table 2: Formal criteria regarding prescriber and patient whose name appears on prescriptions in 2005 (n = 597) and 2010 (n = 633).
2005 2010
n % n % p
Prescriber-related information*
Date 559 93.6 626 98.9 <0.0001
Physician’s name (stamp) 594 99.5 630 99.5 1.00
Physician’s signature 596 99.8 624 98.6 0.0215
Patient-related information
Surname 597 100.0 632 99.8 1.00
First name 597 100.0 629 99.4 0.1250
Date of birth 525 87.9 486 76.8 <0.0001
Age or year of birth 584 97.8 587 92.7 <0.0001
Gender**/+ 216 36.2 55 8.7 <0.0001
Weight** 137 22.9 222 35.1 <0.0001
Patient’s label** 216 36.2 55 8.7 <0.0001
* Hospital address and phone numbers pre-printed. ** Optional. + On the patient’s label.
Table 3: Formal criteria regarding the drugs appearing on prescriptions in 2005 (n = 1,456) and 2010 (n = 1,348).
Drug-related information 2005 2010
n % n % p
Prescriptions with just the drug names 185 12.7 197 14.6 0.152
Detailed prescriptions 1,271 87.3 1,151 85.4 0.152
Drug name 1,271 100.0 1,151 100.0 1.00
Pharmaceutical form 943 74.2 829 72.0 0.2329
Strength / concentration 828 65.1 588 51.1 <0.0001
Prescribed dose 1,089 85.7 1,008 87.6 0.1891
Frequency of administration 1,256 98.8 1,080 93.8 <0.0001
Quantity / number of packages 1,082 85.1 823 71.5 <0.0001
Treatment duration* 408 32.1 446 38.7 0.0007
Route of administration* 119 9.4 144 12.5 0.0154
Instruction* 181 14.2 104 9.0 <0.0001
* Optional.
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The vast majority of medicines were marketed ones, and
very few called for an extemporaneous formulation in a
community pharmacy. Comparing our data with those of
hospitalised paediatric patients [19], it appears that the lat-
ter were prescribed a larger average number of marketed
medicines as well as personalised formulations, due to
more complex pathologies.
In this study, eleven drugs were common to both periods
of the study. We have noted a larger number of prescrip-
tions for ibuprofen in 2010, confirming that this NSAID
has become a commonplace drug in paediatrics [20]. After
a reassessment of the therapeutic value of antitussive drugs
by registration authorities [21], two of them were with-
drawn between the two periods and, hence, were no longer
prescribed in 2010. During both study periods, more than
3/4 of the prescribed medicines were reimbursed by health
insurance companies. Non-reimbursed medicinal products
included mainly the physiological rinsing solution and nas-
al decongestants.
The proportion of drugs prescribed as INN or as generics
increased between 2005 and 2010. Nevertheless, the pro-
portion of prescribed generics remains limited for this cat-
egory of patients (ibuprofen and mefenamic acid tablets,
antibiotics), whereas a generic medicine does not exist in
Switzerland for a majority of over-the-counter drugs (e.g.,
paracetamol, ibuprofen syrup). Pharmaceutical companies
producing generics focus only on economic aspects and of-
ten neglect paediatric needs. It is also interesting to note
that when a drug prescribed to hospitalised patients exists
in generic form, physicians also tend to prescribe it to out-
patients. This is particularly true for antibiotics. However, a
branded prescription always remains a deep anchored habit
for numerous physicians, and only repeated incentive is ex-
pected to change this situation [22].
Formal data concerning the prescribers were filled in a
rather satisfactorily manner. For 2010, we have even noted
an improvement as far as the prescription date was con-
cerned. Formal data about patients were also specified in
a rather comprehensive manner, except for weight, which
is critical information in paediatrics. Data on medicines
were less satisfactory, more than half of the prescriptions
being incomplete. Such gaps rendered numerous prescrip-
tions ambiguous and created a danger of misinterpretation
by community pharmacists. As far as formal aspects are
concerned, our results compare well with those of Kennedy
and Littenberg [23], and are more comprehensive than
those of Paul et al. [24] obtained with adult outpatients.
In the present study, many names of patients were poorly
legible, and one drug was completely illegible. Such a
situation is often encountered in community pharmacies,
obliging pharmacists to seek the opinion of one or more
colleagues. In comparison, Kaushal et al. found 670 il-
legibility errors in 1,782 patients with 2,259 prescriptions
(29.7%) [10].
In our study the number of errors more than doubled
between 2005 and 2010. One third of such errors were
caused by changes in marketed medicines, some being
withdrawn or having changed their trade name. The in-
crease could also be due to the fast turnover of junior physi-
cians, to their more important workload, and to the fact that
a higher proportion of them were non-native French-speak-
ers, or even have not been trained in Switzerland, thus re-
quiring a longer period to adapt to local practice. Most of
the prescription errors do not put patients at risk and could
be easily avoided by consulting appropriate databases. A
direct comparison of our study with similar studies is dif-
ficult because of differences in methodology, with percent-
ages of errors varying from 2.2% to 81% [5–10].
Omissions and errors oblige community pharmacists to
complete or correct errors by consulting with the physician,
the patient, or their parents. This results in a loss of time
and possibly delays in delivery, especially if the physician
is out of reach. Computerised prescription coupled with
advanced decision support is a well-known strategy that
decreases the danger of medication errors [9]. Recently,
Moniz et al. showed that the electronic transmission of pre-
scriptions to community pharmacies led to a decrease in
such errors [25].
Our study had three limitations. First, the analysis of the
prescriptions was restricted to written documents. Oral in-
structions of the physicians to patients or their parents re-
mained unknown. Second, it covered only the winter peri-
od. Other classes of drugs could have been prescribed in
summer. Third, this study focuses mainly on prescription
problems and errors and was not designed to detect adverse
drug events or dispensing errors in community pharmacies
nor administration errors by patients or parents. Other stud-
Table 4: Prescription problems and errors.
2005 2010
Criteria n (%) n (%) p
Poorly legible patient’s name* 55 (9.2) 72 (11.4) 0.2239
Poorly legible drug prescription** 47 (3.2) 70 (5.2) 0.0105
Incomplete drug prescription** 808 (55.5) 933 (69.2) <0.0001
Ambiguous drug prescription** 333 (22.9) 375 (27.8) 0.0027
No of drug prescriptions containing an error** 43 (3.0) 92 (6.8) <0.0001
Illegible drug name 0 1
Drug out of the market 4 16
Wrong name 0 20
Wrong pharmaceutical form 6 9
Wrong strength / concentration 15 11
Wrong dose or frequency of administration 7 12
Wrong quantity / no of packages+ 11 23
* n = 597 (2005) and 633 (2010); ** n = 1,456 (2005) and 1,348 (2010); + duration of treatment specified in the prescriptions.
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ies are definitely needed to understand the effect these dis-
tinct steps in the use of medicines by outpatients.
In conclusion, this study clearly showed that fifteen dif-
ferent drugs (or associations of drugs) represented 80% of
the total of prescriptions, with a quarter being prescribed as
INN or generics in 2010, and that handwritten prescriptions
contained numerous omissions and preventable errors. Fur-
thermore, the formal quality of the prescriptions decreased
from 2005 to 2010 despite regular courses on good pre-
scription practice being given to physicians. Computer-
ised prescriptions coupled with advanced decision support
to achieve a major safety benefit is, therefore, eagerly
awaited.
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